Cargando…

Potential Fluid Biomarkers for the Diagnosis of Mild Cognitive Impairment

Mild cognitive impairment (MCI) is characterized by a level of cognitive impairment that is lower than normal for a person’s age, but a higher function than that that observed in a demented person. MCI represents a transitional state between normal aging and dementia disorders, especially Alzheimer’...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giau, Vo Van, Bagyinszky, Eva, An, Seong Soo A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747411/ https://www.ncbi.nlm.nih.gov/pubmed/31450692 http://dx.doi.org/10.3390/ijms20174149

Ejemplares similares

COVID-19 Genetic Variants and Their Potential Impact in Vaccine Development
por: Vo, Giau Van, et al.
Publicado: (2022)

Transcriptomics in Alzheimer’s Disease: Aspects and Challenges
por: Bagyinszky, Eva, et al.
Publicado: (2020)

Genetic Factors of Cerebral Small Vessel Disease and Their Potential Clinical Outcome
por: Giau, Vo Van, et al.
Publicado: (2019)

Role of apolipoprotein E in neurodegenerative diseases
por: Giau, Vo Van, et al.
Publicado: (2015)

Additional diagnostic testing of the 2019 novel coronavirus (SARS-CoV-2)
por: Vo, Van Giau, et al.
Publicado: (2020)

Genome-editing applications of CRISPR–Cas9 to promote in vitro studies of Alzheimer’s disease
por: Giau, Vo Van, et al.
Publicado: (2018)

Characterization of mutations in PRNP (prion) gene and their possible roles in neurodegenerative diseases
por: Bagyinszky, Eva, et al.
Publicado: (2018)

Analysis of 50 Neurodegenerative Genes in Clinically Diagnosed Early-Onset Alzheimer’s Disease
por: Giau, Vo Van, et al.
Publicado: (2019)

Role of Body-Fluid Biomarkers in Alzheimer’s Disease Diagnosis
por: Nguyen, Thuy Trang, et al.
Publicado: (2020)

APP, PSEN1, and PSEN2 Mutations in Asian Patients with Early-Onset Alzheimer Disease
por: Giau, Vo Van, et al.
Publicado: (2019)

A pathogenic PSEN2 p.His169Asn mutation associated with early-onset Alzheimer’s disease
por: Giau, Vo Van, et al.
Publicado: (2018)

Identification of a novel mutation in APP gene in a Thai subject with early-onset Alzheimer’s disease
por: Van Giau, Vo, et al.
Publicado: (2018)

Pathogenic PSEN1 Glu184Gly Mutation in a Family from Thailand with Probable Autosomal Dominant Early Onset Alzheimer’s Disease
por: Senanarong, Vorapun, et al.
Publicado: (2020)

Early-onset Alzheimer’s disease patient with prion (PRNP) p.Val180Ile mutation
por: Bagyinszky, Eva, et al.
Publicado: (2019)

A pathogenic PSEN1 Trp165Cys mutation associated with early-onset Alzheimer’s disease
por: Van Giau, Vo, et al.
Publicado: (2019)

Cerebrospinal Fluid Biomarkers for the Diagnosis of Prodromal Alzheimer's Disease in Amnestic Mild Cognitive Impairment
por: Park, Jung Eun, et al.
Publicado: (2019)

Novel prion mutation (p.Tyr225Cys) in a Korean patient with atypical Creutzfeldt–Jakob disease
por: Bagyinszky, Eva, et al.
Publicado: (2019)

Genetic analyses of early-onset Alzheimer’s disease using next generation sequencing
por: Giau, Vo Van, et al.
Publicado: (2019)

PSEN1 p.Thr116Ile Variant in Two Korean Families with Young Onset Alzheimer’s Disease
por: Bagyinszky, Eva, et al.
Publicado: (2018)

Systematic review: fluid biomarkers and machine learning methods to improve the diagnosis from mild cognitive impairment to Alzheimer’s disease
por: Blanco, Kevin, et al.
Publicado: (2023)

CSF Biomarkers in the Early Diagnosis of Mild Cognitive Impairment and Alzheimer’s Disease
por: Papaliagkas, Vasileios, et al.
Publicado: (2023)

Studies of Genetic and Proteomic Risk Factors of Amyotrophic Lateral Sclerosis Inspire Biomarker Development and Gene Therapy
por: Bagyinszky, Eva, et al.
Publicado: (2023)

Systematic Review: microRNAs as Potential Biomarkers in Mild Cognitive Impairment Diagnosis
por: Ogonowski, Natalia, et al.
Publicado: (2022)

Recent advances in the treatment of pathogenic infections using antibiotics and nano-drug delivery vehicles
por: Van Giau, Vo, et al.
Publicado: (2019)

Pathogenic PSEN1 Thr119Ile Mutation in Two Korean Patients with Early-Onset Alzheimer’s Disease
por: Bagyinszky, Eva, et al.
Publicado: (2020)

Recent advances in the treatment of C. difficile using biotherapeutic agents
por: Giau, Vo Van, et al.
Publicado: (2019)

Epitope Mapping Immunoassay Analysis of the Interaction between β-Amyloid and Fibrinogen
por: Van Giau, Vo, et al.
Publicado: (2019)

Brain metabolism and cerebrospinal fluid biomarkers profile of non-amnestic mild cognitive impairment in comparison to amnestic mild cognitive impairment and normal older subjects
por: Coutinho, Artur M N, et al.
Publicado: (2015)

Neurogranin as a cognitive biomarker in cerebrospinal fluid and blood exosomes for Alzheimer’s disease and mild cognitive impairment
por: Liu, Weilin, et al.
Publicado: (2020)

Digital Cognitive Biomarker for Mild Cognitive Impairments and Dementia: A Systematic Review
por: Ding, Zihan, et al.
Publicado: (2022)

Plasma biomarkers for diagnosis of Alzheimer's disease and prediction of cognitive decline in individuals with mild cognitive impairment
por: Kivisäkk, Pia, et al.
Publicado: (2023)

New Insights into Potential Biomarkers in Patients with Mild Cognitive Impairment Occurring in the Prodromal Stage of Dementia with Lewy Bodies
por: Hansen, Niels, et al.
Publicado: (2023)

Racial Disparity in Cerebrospinal Fluid Amyloid and Tau Biomarkers and Associated Cutoffs for Mild Cognitive Impairment
por: Garrett, Stephanie L., et al.
Publicado: (2019)

Genetics of Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS) and Role of Sacsin in Neurodegeneration
por: Bagaria, Jaya, et al.
Publicado: (2022)

Genetics, Functions, and Clinical Impact of Presenilin-1 (PSEN1) Gene
por: Bagaria, Jaya, et al.
Publicado: (2022)

Presenilin-1 (PSEN1) Mutations: Clinical Phenotypes beyond Alzheimer’s Disease
por: Yang, Youngsoon, et al.
Publicado: (2023)

Biomarkers in subtypes of mild cognitive impairment and subjective cognitive decline
por: Eliassen, Carl F., et al.
Publicado: (2017)

Apolipoprotein ε7 allele in memory complaints: insights through protein structure prediction
por: Youn, Young Chul, et al.
Publicado: (2017)

Cognitive impairment in multiple sclerosis: lessons from cerebrospinal fluid biomarkers
por: Gaetani, Lorenzo, et al.
Publicado: (2020)

MRI and cerebrospinal fluid biomarkers for predicting progression to Alzheimer's disease in patients with mild cognitive impairment: a diagnostic accuracy study
por: Richard, Edo, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_uhj59c4a52pfp6k34i4te11mfn